Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07441876 |
| Consolidated Lead Sponsor | BioMarin Pharmaceutical |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 160 participants (ESTIMATED) |
| Registered Start Date | 2026-04-20 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| UCSF Benioff Children's Hospital Oakland | Oakland, CA | Open Hospital Dossier -> |
| Northwestern Memorial and Lurie Cancer Center | Chicago, IL | Open Hospital Dossier -> |
| Johns Hopkins Hospital and Kimmel Cancer Center | Baltimore, MD | Open Hospital Dossier -> |
| Cincinnati Children's Hospital Medical Center | Cincinnati, OH | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for BioMarin Pharmaceutical across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.